First Header Logo Second Header Logo

Connection

Haodong Xu to Predictive Value of Tests

This is a "connection" page, showing publications Haodong Xu has written about Predictive Value of Tests.
Connection Strength

0.385
  1. Fishbein GA, Grimes BS, Xian RR, Lee JM, Barjaktarevic I, Xu H. Primary salivary duct carcinoma of the lung, mucin-rich variant. Hum Pathol. 2016 Jan; 47(1):150-6.
    View in: PubMed
    Score: 0.107
  2. Arcega R, Yong WH, Xu H. Malignant melanoma mimicking giant cell variant of glioblastoma multiforme: a case report and review of literature. Int J Clin Exp Pathol. 2015; 8(5):5929-33.
    View in: PubMed
    Score: 0.104
  3. Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011 Jul; 19(4):313-7.
    View in: PubMed
    Score: 0.080
  4. Mentrikoski MJ, Ma L, Pryor JG, McMahon LA, Yang Q, Spaulding BO, Scott GA, Wang HL, Xu H. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. Mod Pathol. 2009 Dec; 22(12):1582-7.
    View in: PubMed
    Score: 0.071
  5. Xiong Y, Bai Y, Leong N, Laughlin TS, Rothberg PG, Xu H, Nong L, Zhao J, Dong Y, Li T. Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies. Diagn Pathol. 2013 Feb 18; 8:27.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.